Advancing Clinical and Transformational Research with Informatics at the University of Kansas Medical Center by Waitman, Lemuel Russell et al.
 90 
 
 
 
Advancing Clinical and Transformational Research with  
Informatics at the University of Kansas Medical Center 
 
Lemuel Russell Waitman1, Gerald Lushington2, Judith J. Warren3 
 
iomedical Informatics accelerates scientific discovery and improves patient 
care by converting data into actionable information. Pharmacologists and biol-
ogists receive improved molecular signatures; translational scientists use tools 
to determine potential study cohorts; providers view therapeutic risk models indi-
vidualized to their patient; and policy makers can understand the populations they 
serve. Informatics methods also lower communication barriers by standardizing ter-
minology describing observations, integrating decision support into clinical systems, 
and connecting patients with providers through telemedicine.  
The University of Kansas Medical 
Center’s (KUMC) decision to pursue a 
National Institutes of Health (NIH) Clin-
ical and Translational Science Award 
(CTSA)1 in partnership with other re-
gional academic medical centers, univer-
sities, and health systems catalyzed the 
development and integration of infor-
matics capabilities to specifically sup-
port translational research in our region 
and to address issues and needs like 
those identified above. Headquartered at 
KUMC, the NIH-CTSA-supported Fron-
tiers program, also called The Heartland 
Institute for Clinical and Translational 
Research (HICTR), is a network of scien-
tists from institutions in Kansas  
and the Kansas City region 
(www.FrontiersResearch.org). The vi-
sion for the informatics section is to pro-
vide rich information resources, services, 
and communication technologies across 
the spectrum of translational research.  
Broadly the initiative would: a) 
adopt methods which facilitate collabo-
ration and communication both locally 
and nationally, b) convert clinical sys-
tems into information collection systems 
for translational research, c) provide in-
novative and robust informatics drug 
and biomarker discovery techniques, d) 
work with state and regional agencies to 
provide infrastructure and data man-
agement for translational outcomes re-
search in underserved populations, and 
e) measure clinical information systems’ 
ability to incorporate translational re-
search findings.  
The specific aims for informatics 
target translational needs requiring fur-
ther investment and complement the 
novel methods and technologies of our 
region: a) the Institute for Advancing 
Medical Innovation’s (IAMI)2 effort in 
drug discovery and b) the Personalized 
Medicine Outcomes Center at the Uni-
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versity of Missouri- Kansas City 
(UMKC) which seeks to understand the 
determinants of health systems’ out-
comes and develop methods to deliver 
evidence based practice. Four aims were 
articulated: 
1. Provide a portal for investigators 
to access clinical and translational re-
search resources, track usage and out-
comes, and provide informatics consul-
tation services.  
2. Create a platform, HERON 
(Healthcare Enterprise Repository for 
Ontological Narration), to integrate clin-
ical and biomedical data for translational 
research.  
3. Advance medical innovation by 
linking biological tissues to clinical phe-
notype and the pharmacokinetic and 
pharmacodynamic data generated by 
research in phase I and II clinical trials 
(addressing T1 translational research).  
4. Leverage an active, engaged 
statewide telemedicine and Health In-
formation Exchange (HIE) to enable 
community based translational research 
(addressing T2 translational research). 
This article will focus on Frontiers’ 
plan and progress in achieving these 
aims since the grant was awarded in 
June 2011.  
Background  
The University of Kansas has a wide 
range of informatics capabilities, devel-
oped over decades of research and ser-
vice. Through the National Center for 
Research Resources (NCRR) IDeA Net-
works for Biomedical Research Excel-
lence (INBRE), the Kansas’ KINBRE has 
created a ten campus network of collab-
orative scientists using common bioin-
formatics resources. Kansas has pio-
neered the use of telemedicine since the 
early 1990s, providing inter-state con-
nectivity at over 100 sites and conduct-
ing thousands of clinical consultations 
and hundreds of educational events for 
health care professionals, researchers, 
and educators.  
The Center for Health Informatics’ 
Simulated E-hEalth Delivery System, a 
jointly funded program between the 
University of Kansas and Cerner Corpo-
ration, creates an equitable partnership 
to fully integrate applied clinical infor-
matics into an academic setting and 
supports over 40 international academic 
clients. These existing efforts are com-
plemented by more recent investments 
in clinical research informatics and med-
ical informatics.  
Starting in 2005, KU selected Velos 
e-Research for our Clinical Research In-
formation System (CRIS). CRIS is a web 
application, supports Health Level 7 
messaging for systems integration, and 
complies with industry and federal 
standards (CFR Part 11) for FDA regu-
lated drug trials. It consists of a man-
agement component for patients, case 
report forms, and protocols, and allows 
financial management for conducting 
studies with administrative dashboards 
and milestones for measuring research 
effectiveness. KU’s support and staffing 
serves not only support KU investigators 
but also to provide enterprise licensing 
for Frontiers’ investigators to conduct 
multi-center, cooperative group, and in-
vestigator-initiated research with CRIS 
across unlimited participating locations 
without additional license fees. CRIS has 
been deployed throughout our institu-
tion and the team has experience sup-
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porting multicenter trials across the na-
tion. 
Bioinformatics is a critical technolo-
gy for translational (T1) research that 
systematically extracts relevant infor-
mation from sophisticated molecular 
interrogation technologies. Analytical 
techniques–such as microarray experi-
ments, proteomic analysis and high 
throughput chemical biology screening–
can probe disease etiology, aid in devel-
opment of accurate diagnostic and 
prognostic measures, and serve as a ba-
sis for discovering and validating novel 
therapeutics. HICTR institutions benefit 
from strong molecular bioinformatics 
research expertise distributed across 
three synergistic entities: the Center for 
Bioinformatics at KU-Lawrence (CBi), 
the Bioinformatics and Computational 
Life Sciences Research Laboratory 
(BCLSL), and the K-INBRE (Kansas 
IDeA Network for Biomedical Research 
Excellence) Bioinformatics Core (KBC). 
Over time, CBi (an internationally rec-
ognized structural biology modeling re-
search program, focusing on computa-
tional structural biology) and BCLSL (a 
research program, led by the School of 
Engineering at KU-Lawrence and focus-
ing on development of sophisticated al-
gorithms for mining biological data) 
should grow into collaborative partners 
for Frontiers investigators.  
The University of Kansas Center for 
Health Informatics (KU-CHI), estab-
lished in 2003, is an interdisciplinary 
center of excellence designed to advance 
health informatics through knowledge 
integration, research, and education of 
faculty and students in the expanding 
field of biomedical science and infor-
mation technology. Like many funded 
CTSA programs, KU is a founding 
member of the American Medical In-
formatics Association’s (AMIA) Aca-
demic Forum. Graduate health informat-
ics education, continuing education, 
AMIA 10x10 program, consultation, and 
staff development workshops/seminars 
designed to advance health informatics 
are sponsored or co-sponsored through 
KU-CHI. Graduate education in health 
informatics began in 2003 in the School 
of Nursing and is now a multidiscipli-
nary master’s degree program offered by 
the Office of Graduate Studies and man-
aged by the KU-CHI. Helen Connors, 
PhD, RN, FAAN (executive director of 
KU-CHI) chairs the State of Kansas E-
Health Advisory Council that oversees 
the development of the state’s health in-
formation exchange strategic and opera-
tional plans and is a board member of 
the Kansas City Bi-state Health Infor-
mation Exchange, the metropolitan ar-
ea’s Regional Health Information Organ-
ization.  
Under the direction of Dr. Ryan 
Spaulding, The University of Kansas 
Center for Telemedicine & Telehealth 
(KUCTT) is a leader in telehealth ser-
vices and research. The program began 
in 1991 with a single connection to a 
community in western Kansas. The Kan-
sas telehealth network now is used to 
connect 60 health facilities in Kansas 
each year. It also is the basis for several 
national and international collabora-
tions, demonstrating significant poten-
tial of telehealth technologies to elimi-
nate distance barriers. Over the last 19 
years, nearly 30,000 clinical consulta-
tions have been conducted across nu-
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merous allied health, nursing and medi-
cal specialties, making the KUCTT one 
of the earliest and most successful tele-
health programs in the world. In 2009, 
over 5000 Kansas patients benefited 
from telemedicine services that included 
clinical consultations, community educa-
tion, health screenings and continuing 
education for health professionals. 
Through the Midwest Cancer Alliance 
(MCA) alone, the KUCTT supported 
numerous second opinion cancer consul-
tations, multidisciplinary tumor board 
conferences, chemotherapy administra-
tion courses and routine patient consul-
tations. Other specialties facilitated by 
the KUCTT include cardiology, psychol-
ogy, psychiatry, neurology, wound care, 
etc. The KUCTT also has been very ac-
tive integrating numerous technologies 
to support clinical and research activi-
ties, including telehealth systems, elec-
tronic health records, data registries and 
patient management systems.  
In 2010, KU committed $3.5 million 
dollars over the next five years towards 
medical informatics academics and ser-
vice, and established the Division of 
Medical Informatics in the Department 
of Biostatistics, to integrate clinical re-
search informatics, and to provide over-
all leadership for the Frontiers Biomedi-
cal Informatics program. Coincidental 
with establishing the division, the Uni-
versity of Kansas Hospital completed 
their five-year, $50 million investment to 
implement the Epic Electronic Medical 
Record, concluding with Computerized 
Provider Order Entry in November 2010. 
This effort has transformed the inpatient 
environment. Subsequently, the Univer-
sity of Kansas Physicians began adop-
tion of Epic across all ambulatory clinics.  
Planned Program Objectives and 
Progress. 
Aim #1: Provide a Frontiers portal 
for investigators to access clinical and 
translational research resources and 
provide informatics consultative ser-
vices.  
As shown at the top of Figure 1, a 
web application to link research re-
sources and foster communication was 
seen as an underlying need. It provides 
investigators access to request services 
from the Translational Technologies and 
Resource Center, the Participant & Clini-
cal Interactions Resources, the Commu-
nity Partnership for Health, and the Eth-
ics section. It also allows investigators to 
obtain targeted internal and extramural 
funding opportunities, request biostatis-
tics support and clinical research data-
base construction, request and access 
informatics resources, and explore edu-
cational offerings.  
A key component of the portal is the 
adoption of REDCap4 (Research Elec-
tronic Data Capture), to create databases 
to manage requests and triage review 
and tracking of requests. Medical Infor-
matics implemented REDCap in January 
2011 to provide a self-service database 
management system for clinical and 
translational research. Since users be-
come familiar with the ease of use and 
development of forms, it was a natural 
approach to also extend the use of RED-
Cap to manage research request activi-
ties. Thus, the user focused portal is 
complemented by using REDCap to help 
Frontiers management track projects, 
distribute resources, and facilitate evalu-
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ation similar to efforts at Vanderbilt 
University3. Frontiers adoption of RED-
Cap has been dramatic with over 700 
users of over 500 projects either under 
development or in production. REDCap 
usage has ranged from student research 
projects as part of a fourth year Health 
of the Public medical school course to 
providing the data management infra-
structure for a $6.3 million NIH funded 
Alzheimer’s Disease Core Center grant.  
In addition to the existing capabilities of 
the CRIS, there are several informatics 
specific components have been devel-
oped to provide better integration for 
clinical and translational researchers. 
Integrated authentication between the 
portal, the campus Central Authentica-
tion Service, CRIS, and i2b2 streamlines 
access to our clinical data repository de-
scribed in the second aim. REDCap was 
used to develop secure methods for the 
process for submitting data requests and 
receiving data and complementary 
methods to support Data Request Over-
sight Committee activities. Finally, we 
provided a request management infor-
matics consult service and training de-
scribed below. 
With the award of the CTSA, we an-
ticipated the need to dedicate a clinical 
informaticist to match investigators’ 
needs against current information avail-
able in Frontiers resources, specifically 
the HERON repository described in Aim 
2. By early 2012, we had recruited Tama-
ra McMahon to serve in this role as the 
clinical informatics coordinator. She as-
sists users with tools like i2b2 and will 
recommend alternative approaches 
when required data are not integrated. 
She and the larger team’s experience 
from front-line consulting with transla-
tional researchers drives prioritizing ad-
Figure 1. Conceptual Model of Biomedical Informatics and Specific Aims 
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ditional data sources, terminology and 
ontology development and guides the 
adoption of new technologies for data 
retrieval and analysis. As we’ve matured 
as a team these consultative services, 
while lead by the coordinator, are 
staffed and addressed by the combined 
biomedical informatics personnel. Addi-
tionally, informatics clinics have been 
established biweekly for investigators, 
staff, and students to attend and discuss 
needs and solutions in an informal 
group setting. Requests for bioinformat-
ics and computational biology capabili-
ties are facilitated by the Bioinformatics 
Resources section of the portal and sup-
port by the bioinformatics assistant di-
rector (initially Dr. Gerald Lushington; 
currently Dr. Paul Terranova).  
Aim #2: Create a platform, HERON 
(Healthcare Enterprise Repository for 
Ontological Narration), to integrate 
clinical and biomedical data for transla-
tional research.  
Transforming observational data in-
to information and knowledge is the 
cornerstone of informatics and research. 
The opportunity for data driven 
knowledge discovery has exploded as 
health care organizations embrace clini-
cal information systems. However, when 
dealing with confidential patient infor-
mation, science and technology are de-
pendent on law, regulation, organiza-
tional relationships, and trust. HERON 
provides Frontiers with secure methods 
for incorporating clinical data into 
standardized information aligned with 
national research objectives. It facilitates 
hypothesis generation, allows assessing 
clinical trial enrollment potential, and 
minimizes duplicate data entry in clini-
cal trial data capture, outcomes research, 
and evaluation of T2 interventions for 
translating research into practice. While 
initially focused on integrating data be-
tween the KU Medical Center, the KU 
Hospital, and KU affiliated clinics, our 
methods are designed to subsequently 
integrate information among all Fron-
tiers network institutions.  
Beginning in April 2009, the Fron-
tiers started piloting a participant regis-
try in the clinics which allows patients to 
quickly consent to be contacted by clini-
cal researchers. The registry contains the 
consented patients’ demographics, con-
tact information, diagnoses, and proce-
dure codes. From April to July 2010, the 
medical center, hospital and clinics re-
viewed comparable practices5,6,7,8 and 
drafted a master data sharing agreement 
between the three organizations that was 
signed September 6, 2010. The HERON 
executive committee is composed of sen-
ior leadership (e.g. chief operating, fi-
nancial, executive officers and chief of 
staff) from the hospital, clinic and medi-
cal center and provides governance for 
institutional data sharing. Establishing 
business processes and servicing re-
search requests is conducted by the Data 
Request Oversight Committee (DROC) 
which reports to the HERON executive 
committee. The repository’s construc-
tion, oversight process, system access 
agreement, and data use agreement for 
investigators were approved by the In-
stitutional Review Board. Since HERON 
is currently funded by KU and contains 
medical center and affiliated clinics and 
hospital data, access requires a medical 
center investigator. As additional institu-
tions and health care organizations pro-
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vide support and contribute data, they 
will be incorporated with multi-
institutional oversight provided by the 
HERON executive committee and 
DROC.  
As agreed upon by the HERON ex-
ecutive committee, HERON has four us-
es: cohort identification, de-identified 
data, identified data, and participant 
contact information: 
After signing a system access 
agreement, cohort identification queries 
and view-only access is allowed and ac-
tivity logs are audited by the DROC.  
Requests for de-identified patient 
data, while not human subjects research, 
are reviewed by the DROC.  
Identified data requests require ap-
proval by the Institutional Review Board 
prior to DROC review. After both ap-
provals, medical informatics staff will 
generate the data set for the investigator.  
Investigators who request contact 
information for cohorts from the HICTR 
Participant Registry have their study re-
quest and contact letters reviewed for 
overlap with other requests and adher-
ence to policies of the Participant and 
Clinical Interactions Resources Program 
Data Request Committee.  
The utility of data for clinical re-
search is proportional to the amount of 
data and the degree to which it is inte-
grated with additional data elements 
and sources. However, as additional da-
ta are integrated and a richer picture of 
the patient is provided, privacy concerns 
increase. HERON receives and preserves 
data into an identified repository, links 
and transforms those data into de-
identified, standardized concepts, and 
allows users to retrieve data from this 
separate de-identified repository (See 
Figure 2). We recognize that certain re-
search requires access to identified data 
but our approach streamlines oversight 
when needs are met with de-identified 
data. We adopted the NIH funded i2b29 
software for user access, project man-
agement, and hypothesis exploration 
and chose Oracle as our database be-
cause of existing site licensing and i2b2 
compatibility. Transformation and load 
activities are written in the python lan-
guage and deployed onto SUSE LINUX 
servers. Servers are maintained in the 
medical center and hospital’s data center 
which complies with HIPAA standards 
for administrative, technical and physi-
cal safeguards.  
Maximizing data sharing to adhere 
to NIH guidelines has been a key goal 
for the development of HERON. Our 
goals are to make scientific data and in-
formatics methods available as widely as 
possible while safeguarding the privacy 
of our patients. Our data sharing agree-
ments were developed at an organiza-
tional level to streamline requests for de-
identified data. Our repository’s use of 
i2b2 and UMLS terminologies facilitate 
national collaboration. By using open 
source development tools and languages 
all new software developed using sup-
port from the NIH grant is then made 
available to others through our divi-
sion’s research and development web-
site: http://informatics.kumc.edu.  
Access to the identified repository is 
highly restricted and monitored. Data 
exchange between source systems, 
HERON, and user access is handled via 
security socket layer communications, 
https with digital certificates, and 128-bit 
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or higher public key cryptography (ex: 
SSH-2). We will continue to monitor 
federal guidance regarding appropriate 
security measures for healthcare infor-
mation10. User access, activity logs, and 
project management for the de-
identified repository is managed via the 
i2b2 framework and is integrated with 
the medical centers’ open source Jasig 
Central Authentication Service and the 
HICTR portal. Account creation and ac-
cess control is provided by the medical 
center. Audit logs are maintained for 
both the identified and de-identified re-
positories. Intrusion detection mecha-
nisms are used and monitored by medi-
cal center Information Resources securi-
ty personnel who also conduct HIPAA 
Security Rule reviews of the systems.  
Current literature highlights chal-
lenges with providing anonymity after 
de-identifying data11,12,13,14. While we re-
move all 18 identifiers to comply with 
HIPAA Safe Harbor, the de-identified 
repository is treated as limited data set, 
reinforced by system access and data use 
agreements. Initially, HERON will only 
incorporate structured data. We will stay 
abreast of best practices (e.g., De-ID, the 
MITRE Identification Scrubber Toolkit 
versus only extracting concepts) prior to 
incorporating narrative text results 
which have greater risk for re-
identification11,15.  
Arvinder Choudhary, our medical 
informatics project director, and Daniel 
Connolly, our lead biomedical informat-
ics software engineer, were responsible 
for the initial construction of HERON. 
Starting in April 2010, the team has de-
ployed a data repository with i2b2 inte-
gration, contributed to the i2b2 commu-
nity code for integration with the Cen-
tral Authentication Service (an open 
source project used by many universities 
for “single sign-on”), worked with other 
CTSA institutions to use the UMLS as a 
source terminology for i2b2, and estab-
lished a software development envi-
ronment for the team using Trac and 
Mercurial. Initial pilot use began as early 
as April for access to the Frontiers Par-
ticipant Registry (diagnoses, de-
mographics, and procedures based on 
clinic billing systems). The current archi-
tecture was deployed in August 2010 
and populated with production data 
from IDX and Epic in September 2010. 
Figure 2. HERON Architecture 
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Initial extract, load, and transform pro-
cesses obtain data files from the source 
system via secure file transfer methods. 
The repository was available as a proof 
of concept in December 2010 and en-
tered beta mode for all faculty in March 
2011. HERON has been updated with 
new data and functionality every month 
since August 2011 (updates advertised 
on our blog:  
http://informatics.kumc.edu/work/blog). 
As of August 2012, HERON is using an 
i2b2 version 1.6 and it contains approx-
imately 850 million facts for 1.9 million 
patients.  
From its inception, HERON has 
benefitted from i2b2 community exper-
tise and the team works with other aca-
demic medical centers to align our ter-
minology with CTSA institutions. Our 
approach is to rely on the National Li-
brary of Medicine Unified Medical Lan-
guage System (UMLS) as the source for 
ontologies and to use existing or develop 
new update processes for the i2b2 On-
tology Management Cell and other sys-
tems. The National Center for Biological 
Ontologies is also working with the i2b2 
development team to create methods 
that can assist organizations using i2b2 
with building appropriate ontologies 
based on the UMLS or other source on-
tologies. This may play a greater role as 
we bridge clinical data towards bioin-
formatics domains and to incorporate 
more recently authored ontologies that 
are not fully supported by the NLM. As 
we develop new mapping for going 
from UMLS into i2b2 and from source 
systems such as Epic, we have shared 
Figure 3. HERON Progress on Incorporating Data Sources and Ontologies
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our code and processes with the i2b2 
community via our website. Figure 3 
illustrates our current progress in build-
ing a rich picture of our patient popula-
tion and highlights places where the 
HERON repository also serves to ad-
vance KUMC’s goal to become a Nation-
al Cancer Institute designated Cancer 
Center.  
The team’s approach leveraged 
methods outlined by several CTSA or-
ganizations that shift mapping inside 
i2b2 instead of in database transfor-
mation and load processes16. This pre-
serves the original data side by side with 
the transformed information allowing 
easier review by investigators and do-
main experts. We applied these methods 
when we incorporated nursing flow-
sheet information17 (vital signs, nursing 
assessments, social status) from the Epic 
electronic medical record. Judith War-
ren, PhD, RN, BC, FAAN, FACMI (Di-
rector of Nursing Informatics, the Center 
for Health Informatics) serves as assis-
tant director of health informatics for 
Frontiers and has extensive experience 
developing health informatics standards 
and terminologies, teaching informatics, 
and developing national policy for 
health information technology. She has 
led several initiatives, especially regard-
ing nursing observations, to adopt 
standards that will maximize data inte-
gration and reuse.  
Our hope is that standardizing in-
formation for research strengthens our 
relationship with the hospital and clin-
ics. Reusing information for clinical 
quality improvement also requires 
Figure  4. Richness of Phenotype in HERON using Frontier Participants as an example 
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standardization. Translational research 
using HERON has highlighted areas 
needing terminological clarity and con-
sistency in the electronic medical record. 
Going forward, we are partnering with 
Dr. Ator, Chief Medical Information Of-
ficer, and the University of Kansas Hos-
pital’s Organizational Improvement 
(which has two of their leaders on the 
DROC) to develop a data driven process 
for improving standardization. Research 
and quality improvement goals also 
align with achieving “meaningful use”18 
and Health Information Exchange activi-
ties. We will gradually build relation-
ships by initially focusing on linking da-
ta sources from KU Hospital and affiliat-
ed clinics. Figure 4 provides an illustra-
tion of how today, patients who volun-
teer to be contacts for research in the 
clinic based upon a clinic billing system 
indicator are linked to medication expo-
sure and laboratory results, allowing 
more targeted recruitment for prospec-
tive clinical trials19. The majority of these 
patients have diagnoses, demographics, 
procedure codes, laboratory results, and 
medications in HERON. As capabilities 
of the team develop we plan to expand 
to other Frontiers affiliated network in-
stitutions, state agencies, and our rural 
practice networks (outlined in aim 4). 
This may require centralized and/or dis-
tributed data integration20,21.  
Aim #3: Advance medical innova-
tion by linking biological tissues to 
clinical phenotype and the pharmaco-
kinetic and pharmacodynamic data 
generated by research in phase I and II 
clinical trials (addressing T1 transla-
tional research).  
We saw two points where Frontiers’ 
informatics must bridge between basic 
science resources and clinical activities 
to enhance our region’s ability to con-
duct translational research. Our region 
provides a wealth of biological and ana-
lytical capabilities but struggles at times 
to understand if our clinical environ-
ments see enough patients to support 
research. This leads to clinical trials 
which fail to accrue enough subjects22. 
Accurately annotating biological tissues 
and routine clinical pathology specimens 
with the patients’ phenotypic character-
istics (such as diagnosis and medications 
from the clinical records) would provide 
a more accurately characterized clinical 
research capacity. Our second targeted 
area is designed to support the Drug 
Discovery and Development activities of 
Frontiers’ Institute for Advancing Medi-
cal Innovation’s (IAMI) initiative in 
managing information in phase I and II 
clinical trials. Molecular biomarker and 
pharmacokinetics/pharmacodynamics 
research activities provide high quality 
analysis, but their results are not easily 
integrated with other records main-
tained in clinical research information 
systems. Reciprocally, if clinical charac-
teristics could be provided with samples 
in a standardized manner it would allow 
improved modeling and analysis by the 
core laboratories. Collaboration between 
the bioinformatics and biomedical in-
formatics specifically targeted at bio-
specimens, pharmacokinetic /pharmaco-
dynamic results and clinical trials will 
provide a foundation for subsequent in-
tegration and our final goal of providing 
molecular bioinformatics methods.  
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Aligning CTSA capabilities with our 
Cancer Center’s pursuit of national des-
ignation was a top T1 priority for the 
informatics team. Our ability to incorpo-
rate clinical pathology based infor-
mation and the biological tissue reposi-
tories with HERON could improve co-
hort identification, clinical trial accrual, 
and clinical trial characterization. Pa-
tients’ tissue specimens are a fundamen-
tal resource that links the majority of 
basic biological science analysis to clini-
cal relevance. We need to improve our 
characterization of these samples to 
maximize our investment in maintaining 
them for clinical research. By integrating 
clinical pathology derived characteristics 
and research specimens with clinical in-
formation in HERON, researchers can 
quantify samples belonging to patients 
(e.g. aggregating all breast cancer diag-
noses using the i2b2 clinical concept 
“malignant neoplasm of the breast” and 
treated with the adjuvant therapy 
Trastuzumab).  
On July 12, 2012, KU 
was awarded NCI Cancer 
Center Designation, the 
highest priority strategic 
objective for the university. 
Informatics contributed by 
enhancing i2b2 for cancer 
research by incorporating 
key data sources and de-
veloping methods for con-
ducting real time survival 
analysis. Our first step to-
wards supporting T1 re-
search was integrating the 
Biological Tissue Reposito-
ry (BTR) in the Translational 
Technologies and Resource 
Center (Section 8) and 
HERON. The BTR, built 
upon the existing KU Can-
cer Center Biospecimen 
Shared Resource, plays a 
vital role in collecting and 
distributing high quality 
human biospecimens es-
sential to research. Improv-
ing specimen management 
for clinical research has 
been identified as a high Figure 5. Initial ontology for Biospecimen Tissue Repository 
Integration within HERON 
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priority initiative for KU. Integrating the 
BTR allows users to exploit the pheno-
typic data in HERON to characterize the 
samples. BTR personnel can also use this 
linkage to provide investigators request-
ing samples with clinical phenotype 
from HERON via a data use request ap-
proved by the oversight committee. Fig-
ure 5 demonstrates the ontology for bio-
specimens within HERON’s i2b2 appli-
cation. We are currently migrating the 
BTR to reside within the Comprehensive 
Research Information System (CRIS). 
This will enhance analysis and charac-
terization of data from clinical trials and 
also improve inventory management, 
retrieval, and quality assurance process-
es for the BTR staff. 
Our second step was to incorporate 
the hospital’s Tumor Registry within 
HERON since the validated tumor regis-
try provides additional tumor character-
istics for the cancer population, out-
comes, and follow up information that 
are not maintained in surgical pathology 
systems. The tumor registry was incor-
porated with collaboration from Kimmel 
Cancer Center (PA) and Group Health 
Cooperative (WA) and leveraged using 
the national standard for tumor registry 
data specified by the North American 
Association for Central Cancer Registries 
(NAACCR). We also incorporated the 
social security death index from the Na-
tional Institutes for Standards and Tech-
nology to provide support for long term 
outcomes and survival analysis across 
all clinical conditions and health services 
research. Finally, we created rgate – an 
improved method to integrate R with 
i2b2 and Oracle23. Figure 6 provides a 
summary of HERON workflow for hy-
potheses generation and preliminary 
visualization using the interactive analy-
sis tools. Future work will focus on gen-
eralizing plugins for multiple cohorts 
beyond cancer and extending the use of 
R analysis within HERON so that initial 
validation can be conducted without 
needing to request data from HERON. 
 
Figure 6. HERON providing interactive survival analysis 
 103 
 
That in turn reduces the risk of acci-
dental data disclosure.  
Going forward, we plan to support 
IAMI clinical trials by integrating and 
standardizing information between the 
bioinformatics and pharmacokinet-
ic/pharmacodynamic (PK/PD) program 
and CRIS. The Institute for Advancing 
Medical Innovation (IAMI) builds upon 
the region’s significant drug discovery 
capabilities and creates a novel platform 
for medical innovations. Members of the 
K-INBRE Bioinformatics Core (KBC) 
provide bioinformatics analysis across 
the spectrum of target discovery, com-
pound screening, lead identification and 
optimization, and preclinical develop-
ment. As drug candidates successfully 
transition to a new investigational drug 
application, we will continue bioinfor-
matics support into clinical trials.  
Through Frontiers we hope to estab-
lish stronger bridges between analytical 
resources and clinical information which 
will allow phenotypic variables to be 
exploited by bioinformatics expertise in 
data mining by the K-INBRE Bioinfor-
matics Core (KBC) and the Bioinformat-
ics and Computational Life Sciences Re-
search Laboratory. Over time, Frontiers 
T1 translational research efforts may be 
enhanced by providing data mining al-
gorithms that extract key information 
from data-intensive wet lab studies and 
integrating those results with phenotype 
derived from clinical applications. This 
bridge between molecular-level analysis 
and clinical studies is a potent model for 
biomarker prediction and validation, 
PK/PD studies, and the prospective re-
finement of personalized medicine.  
Aim #4: Leverage an active, en-
gaged statewide telemedicine and 
Health Information Exchange (HIE) to 
enable community based translational 
research (addressing T2 translational 
research). 
In the latter years of the grant we 
plan to leverage regional informatics ca-
pabilities to complement the long histo-
ry of engaging the community through 
outreach via telemedicine, continuing 
medical education, and our extensive 
community research projects in urban 
rural and frontier settings. We will high-
light the initial areas where Frontiers is 
deploying informatics in support of T2 
community based research.  
Under the leadership of Dr. Helen 
Connors, the Center for Health Informat-
ics has been instrumental for advancing 
HIE for Kansas and the Kansas City bi-
state region. As chair of the eHealth Ad-
visory Council, Dr. Connors guided the 
process to establish the Kansas HIE 
(KHIE)23; a non-profit corporation incor-
porated by the governor in response to 
the federal HITECH Act. Allen Greiner, 
MD, director of the Community Partner-
ship for Health (Section 5), participates in 
selecting electronic health records for the 
Kansas Regional Extension Center and 
Dr. Russ Waitman has participated in 
activities on behalf of Kansas Medicaid 
and technical subcommittees responsible 
for the development of Health Infor-
mation Exchange in the state. The shared 
goal is to keep Frontiers engaged in state 
and regional infrastructure capabilities 
for translational research and facilitate 
identifying other collaborating organiza-
tions. 
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The University of Kansas Center for 
Telemedicine and TeleHealth (KUCTT) 
provides enormous reach into diverse 
communities for implementing clinical 
trials and other research across the state. 
Telemedicine has figured prominently in 
a number of clinical research programs 
(e.g. studies of diagnostic accuracy, cost 
effectiveness, and patient and provider 
satisfaction with telemedicine) as well as 
studies that employ telehealth for ran-
domized control trial interventions. 
Complementing KUCTT, the Midwest 
Cancer Alliance (MCA) is a member-
ship-based organization bringing cancer 
research, care and support professionals 
together to advance the quality and 
reach of cancer prevention, early detec-
tion, treatment, and survivorship in the 
heartland. The MCA links the University 
of Kansas Cancer Center with the hospi-
tals, physicians, nurses and patients bat-
tling cancer throughout Kansas and 
Western Missouri. The MCA advances 
access to cutting-edge clinical trials as 
well as professional education, network-
ing, and outreach opportunities. These 
clinical trials use our Comprehensive 
Research Information System (CRIS). 
Notably, the MCA critical access and 
rural referral centers are also the most 
active participants in telemedicine. The 
medical director of the MCA, Dr. Gary 
Doolittle is a pioneer user and has pub-
lished telemedicine research with Dr. 
Ryan Spaulding, the director of the tel-
emedicine network24,25. The network has 
been successfully used to facilitate clini-
cal research and to support special needs 
populations; especially in the area of 
smoking cessation.  
Biomedical informatics works with 
KUCTT to provide a telemedicine clini-
cal trials network connected by CRIS for 
remote data collection via study person-
nel or direct data entry through a patient 
portal.  
Additionally, in March 2011, Kansas 
City, Kansas “won” a nationwide Re-
quest for Information (RFI) solicitation 
for construction of a next generation 
broadband network by Google achieving 
upload and download speeds of 1 giga-
bit per second (Google 2011). Google 
subsequently announced the expansion 
of service to Kansas City, Missouri for a 
potential deployment of 500,000 indi-
viduals. Through Frontiers, the Univer-
sity of Kansas Medical Center’s (KUMC) 
early support led to a collaborative 
working relationship between KUMC 
Medical Informatics and the Google Fi-
ber team to explore leveraging the tech-
nology to further health care delivery, 
education, and research. On July 26, 
2012, Google unveiled their services and 
began preregistration throughout the 
Kansas City metropolitan area. KUMC is 
actively participating by providing nu-
tritional consults via telepresence as part 
of the Google Fiber Space located a few 
blocks from the medical center campus. 
Building on the strength of telemedicine 
and informatics Drs. Waitman and 
Spaulding are collaborating with the 
School of Nursing and the School of En-
gineering to develop a research proposal 
for the National Science Foundation’s 
US Ignite (www.nsf.gov/usignite) initia-
tive to develop next generation applica-
tions that can exploit ultra-fast networks 
such as Google Fiber.  
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In the coming year, Frontiers plans to 
build upon investment in electronic medi-
cal records by consulting with Frontiers 
investigators to optimize the use of clinical 
systems for disseminating translational ev-
idence and recording measures to verify 
adoption. This work is also foundational to 
medical informatics and will allow the 
evaluation of native clinical information 
system “signals” against manual processes 
used to report measures to government, 
regulatory agencies, and national registries. 
Working with the hospital to develop ca-
pabilities to acquire user activity data to 
measure the systems’ impact on workflow 
and clinical decision making (e.g. drug-
drug interaction overrides, time to com-
plete medication administration task) will 
also help us overcome translational re-
search’s last mile: implementation into clin-
ical workflow.  
Longer term objectives for Frontiers 
will look to develop methods to engage 
with community providers regarding elec-
tronic health record adoption and those 
systems’ capacity to support translational 
research. As mentioned previously, we 
have also made initial inroads regarding 
incorporating state and national data 
sources into HERON as illustrated by our 
incorporation of the Social Security Death 
Index. Over time, we hope to work with 
the Kansas Medicaid program to investi-
gate methods to link health data main-
tained by the state as claims against the 
clinical data in HERON. This will further 
three objectives: (a) national data may pro-
vide outcome measures lacking in acute 
care clinical information systems, (b) na-
tional registries, such as the National Data-
base of Nursing Quality Indicators, can 
evaluate the degree to which manually ab-
stracted measures might be automatically 
derived from a mature clinical information 
system, and (c) data integration will allow 
hypotheses to be explored that suggest 
methods for improving care. Finally, we 
aim to collaborate with Frontier’s Personal-
ized Medicine and Outcomes Center to 
provide complex risk models for decision 
support to a variety of clinical specialties. 
Those investigators have developed meth-
ods that translate complex risk models into 
fully functional decision-support tools for 
physicians as well as personalized educa-
tional and informed consent documents for 
patients.  
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